Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Livzon Pharmaceutical Group ( (HK:1513) ) has issued an announcement.
Livzon Pharmaceutical Group Inc. has announced the composition of its board of directors and the membership of its board committees. This announcement provides clarity on the leadership structure of the company, which could influence its strategic direction and governance practices, potentially impacting stakeholders and the company’s market positioning.
The most recent analyst rating on (HK:1513) stock is a Sell with a HK$24.00 price target. To see the full list of analyst forecasts on Livzon Pharmaceutical Group stock, see the HK:1513 Stock Forecast page.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is known for its comprehensive range of healthcare solutions, catering to various market needs.
Average Trading Volume: 1,090,004
Technical Sentiment Signal: Buy
Current Market Cap: HK$31.19B
For an in-depth examination of 1513 stock, go to TipRanks’ Stock Analysis page.